Foreign-funded medical devices are deployed in the Chinese market

According to some data, the size of China's medical device market in 2017 will reach 597 billion yuan. On this side, the National Health and Family Planning Commission commissioned the China Medical Equipment Association to complete the selection of the first batch of excellent domestic medical equipment . The second batch of selection will be launched recently. On the other hand, foreign giants including Philips, Medtronic and GE Healthcare It is also laying out the Chinese market in the "two divisions of soldiers", competing to achieve localization and sinking channels. In the industry's view, the technology gap between Chinese and foreign-funded products has narrowed, and the price gap has also narrowed. The future competition is more or less "short-handed."

Medical equipment: domestic products rely heavily on selection, foreign competition, localization

"In terms of our clinical purchasing experience, the proportion of domestic medical equipment has indeed increased, but it has not yet reached 50%. The gap between Chinese and foreign product technology and price gap is shrinking, so the competition between the two sides may be more complete and direct." Southern Hospital Xu Yikai, director of the Imaging Center, told this reporter that the biggest advantage of foreign brands lies in core technology. “We recently introduced the Philips Smart Scan iCT, which enables low-dose HD CT imaging to effectively reduce the radiation dose of patients.”

According to the person in charge of the marketing department of Philips Southern Region, it is indeed the Chinese market in the "two divisions of soldiers." “The conventional equipment of the top three cities in the first-tier cities tends to be saturated, but fortunately, there is still room for development of such advanced equipment as low-dose; for the grassroots, Philips has established a grassroots medical team, and the localized products developed are simple, practical, and cost-effective. Characteristics, focusing on emerging markets." It said that in terms of the current environment, the high-end sector is not afraid of domestic products, the low-end market is more under pressure, the grass-roots market is more sensitive to price, and the domestic price is 1/3 cheaper.

Anti-Sepsis And Anti-Inflammation Material

We are a professional Chinese supplier of Anti-Sepsis And Anti-Inflammation Material; we supply various products of Skin Relieve Ingredients ; and we can providing product images and basic parameters with each Anti-Sepsis Material, and Anti-Inflammation Material. Look forward to your cooperation!

Echinacea Purpurea Extract,Emodin Powder,Gynostemma Extract,Sophora Japonica Extract,Ivy Leaf Extract

Xi'an Quanao Biotech Co., Ltd. , https://www.quanaobiotech.com